Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **lumbar intervertebral disc** occupies the space between each pair of lumbar vertebral bodies (L1-L5). Each disc is composed of a tough outer *annulus fibrosus* (fibrous ring) and a central *nucleus pulposus* (gelatinous core), bordered above and below by cartilaginous endplates[1][2][4][8]. These discs function as shock absorbers, cushion the vertebral bodies, prevent friction, and allow for spinal flexibility. While their degeneration or injury is a major cause of lower back pain and related neurological symptoms, the "lumbar intervertebral space" itself is not a direct drug target but rather an anatomical location important in numerous spine-related diseases. Therapy is aimed at relieving symptoms or surgically correcting structural pathology rather than molecular interaction with the space itself[3][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lumbar intervertebral disc.